Document Type
Article
Publication Date
6-1-2026
Abstract
Parkinson’s disease (PD) is a neurodegenerative disorder marked by loss of substantia nigra dopaminergic neurons. Epidemiological evidence indicates that lifelong physical activity reduces both PD incidence and slows disease progression. Here, we examine how voluntary exercise induces long-lasting neuroprotection of the corticostriatal function in a murine model of α-synuclein–driven nigrostriatal pathology. In preformed fibril (PFF)-injected mice, long-lasting voluntary wheel running prevents degeneration of nigrostriatal dopaminergic terminals and improves motor performances. Intensive exercise normalizes spontaneous glutamatergic transmission and preserves corticostriatal long-term potentiation (LTP) in striatal spiny projection neurons. Exercise-induced LTP is dependent on activation of dopamine (DA) DA1, GluN2B-expressing NMDA and CB1 endocannabinoid (eCB) receptors. Pharmacological modulation of exercise-induced plasticity shows that, while in physiological conditions eCBs regulate synaptic depotentiation, persistence of LTP in active α-syn mice occurs independently of the eCB system, highlighting a critical interaction between DA and eCBs in long-term synaptic regulation. These findings identify voluntary exercise as a robust neuroprotective intervention with therapeutic relevance for early PD.
Recommended Citation
Campanelli, Federica; Marino, Gioia; Natale, Giuseppina; De Carluccio, Maria; Rodriguez, Tabitha N.; Smeyne, Michelle; Smeyne, Richard Jay; Ghiglieri, Veronica; and Calabresi, Paolo, "Dopamine-Endocannabinoid Crosstalk Drives Exercise-Induced Bidirectional Plasticity in Parkinson's Disease" (2026). Department of Neuroscience Faculty Papers. Paper 97.
https://jdc.jefferson.edu/department_neuroscience/97
Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
Supplementary_Figure_1.png (480 kB)
Supplementary_Figure_2.png (867 kB)
Supplementary_Figure_3.png (306 kB)
Supplementary_Figure_4.png (286 kB)
Supplementary_Figure_5.png (212 kB)
Supplementary_Figure_6.png (281 kB)
Language
English

Comments
This article is the author's final published version in npj Parkinson's Disease, Volume 12, Issue 1, 2026, Article number 208.
The published version is available at https://doi.org/10.1038/s41531-026-01396-7. Copyright ©The Author(s) 2026.